the trophoblast and the pancreatic enzyme treatment of cancer · enzymes – around day 56 in human...

TheTrophoblastandthePancreaticEnzymeTreatmentofCancer

ByHenrySchneikerFebruary16,2017

Copyright2017–allrightsreservedThisisabriefintroductiontothescience,historyandprotocolsusedtostopcanceranddestroytumorsbasedontheworkofJohnBeardandhistrophoblastictheoryofcancer.Itassemblesacollectionofthelatestmaterialreferencesforthoseinterestedinresearchingthetopic.Anestimated1,685,210newlydiagnosedcancercasesareexpectedintheUSAin2016alongwith595,690expecteddeaths.Worldwidenumbersarefarworse.Inotherwords,roughly1in3peoplediagnosedwithcanceraredyingfromcancer.Themajorkillersarelung,colorectal,pancreasandbreastcancers,inthatorder.Menhavealifetime1in2chanceofgettingcancerwhilewomanhavealifetime1in3chance.Thatroughlytranslatestomenhavinga1in6chanceofdyingfromcancerwhilewomanhavea1in9chanceofdyingfromcancer.FiguresarefromtheNationalCancerInstitute.Withallofthemoneyspentoncancerresearchoverthelast50years,conventionaltreatmentshaveonlyincreasedthe5-yearsurvivalrateofallcancerpatientsby2-3%.Afewisolatedcancershaveseentremendousimprovementswhilemostcancershaveseennosignificantimprovement.Clearly,ifyouareoneofthoseluckyfolks,youareveryhappy.Certaincancershaveamuchhighermortality(death)rate.Forinstance,pancreaticcancerhasamortalityrateapproaching92%over5years.Inotherwords,youhave10chancesoutof11ofbeingdeadin5years–orjust1chancein11ofstillbeingalivein5years.Somesourcesput5-yearmortalityfrompancreaticcancerashighas98%buttheseareprobablyreferringtolatestagediagnosis.53,070peopleareexpectedtobediagnosedwithpancreaticcancerin2016while48,984ofthosepeopleareexpectedtodiewithin5years.Soifyougetdiagnosedwithpancreaticcancer,itmakessensetolookatalternativesthathaveahigher5-yearsurvivalrate.Specifically,youarelookingfortreatmentprotocolsthathaveasolidscientificbasisandawell-documentedsuccessrate.Myresearchhasturneduponetreatmentprotocolthatmeetsthe“solidscientificbasisandawell-documentedsuccessrate”criteriaandisthesubjectofthispaper.NotethatthistreatmentONLYprovidessignificantincreaseintheprobabilityofsurvival.

Thegoldstandardforprovingamedicalprotocol’sefficacy–i.e.,howwellaprotocolworks–isawelldesignedrandomizeddouble-blindhumantrial.Unfortunately,nosuchtrialhasbeendoneontheprotocolbeingpresentedhere.Soyoumustrelyonadifferentstatisticalmethodtojudgehowgoodtheprotocolis.Let’sstaywithpancreaticcancer.Giventhat21outof23peoplediagnosedwithpancreaticcancerdiewithin5years,youhaveagoodbackgroundstatisticalbasisforcomparison.Thosenumberslumptogetherpeoplewhoarediagnosedwithalltypesofpancreaticcancer,allstagesofpancreaticcancerandalltreatmentmodalities.Inotherwords,thosenumbersrepresentthestateoftheart–onaverage–andrepresentthebestthatmodernmedicinecanoffer-onaverage.Ifyouselectasubsetoftheaverage–forinstance,earlydetectionwith“complete”resectionandchemotherapy–your5-yearsurvivalrateimprovestoalmost21%.Youshouldnotethattheresection(operationtoremovethecancer)gotyouthefirst11%whilethechemotherapy(gemcitabine)gotyoutheremaining10%.Youcanusedatafrompublishedtrialstobracketthesurvivalratesundervariousinterestingcircumstances.Youcannowdesignametastudyusingwellkeptpatientrecordstodocumenttheprotocol’ssuccessrateandcomparethattoan“equivalent”controldataset.Itisimportanttounderstandthatthisstudymethodcancontainself-selection,placeboorotherbias.Therearemanyquestionsthatthestudywillnotbeabletoanswer.Forinstance,arethepeopleseekingthistreatmentrepresentativeofthecontrol?Howmanypeoplewerenotgoodcandidatesaftertheirinitialconsultationanddidnotbecomepatients–andhence,therearenocorrespondingpatientrecords?Arepeoplewhochosethisprotocolpredisposedtoaparticularoutcome?Youmusteliminatepatientrecordsthatdonotprovidetheneededinformationorwhodonotmeetthecriteriaforthestudy.Forinstance,youwantbiopsyconfirmationbyamajormedicalfacilitysoyouknowapatientactuallyhadcancerandnotsomethingelse.Youneedtoknowwhatwasdonetothepatientpriortostartingtheprotocol–i.e.,what(conventional)treatmentswereperformedandwhatwasthegeneralhealthofthepatient.Youwantdocumentationthatthepatientfollowedtheprotocol–andifnot,whynot.Apatientmaynotbecapableoffollowingtheprotocolduetobadhealthorbeinginthehospital.Andthenyouneedpatientrecordsthatgoonlongenoughaftertheprotocolstartssoyoucanseehowlongtheylivedafterusingtheprotocol.Seethereferencedlinkbelowforadiscussionabouttheissuesintryingtogeneratemeaningfulstatisticsfromaprivatepractice.Withgoodpatientrecordsandawelldesignedstudy,youcangetagoodideaifaprotocolappearstobeeffectivefromthehistoricalrecord.Youwantthestudytoshowasignificantincreaseinsurvivalratescomparedtoexistingconventional

treatmentprotocols.Suchstudieshavebeendoneandyoushouldlookcarefullyatwhattheyshowbeforeyourelyonthem.Whenyouarediagnosedwithcancer,youhavesomereallytoughdecisionstomake.Doyougoaheadwithconventionaltreatments?Doyoucombineconventionaltreatmentswithawelldocumentedalternativeprotocol?Doyouskiptheconventionaltreatmentsanduseonlythewelldocumentedalternativeprotocol?Unfortunately,onthedayyourcancerisdiscovered,theclockistickingandyoudon’thavealotoftimetoresearchthesubjectandmakeachoice.Tobefair,conventionalchemotherapytreatmentsonlyhavetoshowatemporaryshrinkageintumorsizetobeapproved.Evenifthetumorsregrowafterthetemporaryshrinkage,thetreatmentsarestillapproved.Thereisnorequirementforrandomizeddouble-blindstudiesshowingsignificantlyimproved5-yearsurvivalrates.Andserioussideeffectsarecommon.Extendinglifeforafewweeksorevenmonths–withoutregardtothequalityoflife–isseenasawonderfulsuccessinconventionalmedicine.Sowhyshouldawelldocumentedalternativetreatmenthavetomeethigherstandardsinordertobeaccepted?Onefailingofmodernoncologyisthatthelikelihoodofanyparticularapprovedchemotherapytreatmentworkingchangesfromcancertocancerandpersontoperson.Itisrarethatchemotherapysensitivitytestingisperformedbeforeadministratingchemotherapy–whichwouldallowdoctorstoascertainwhichchemotherapydrugshavealowlikelihoodofworkingonaspecificcancerandeliminatethemfromthetherapy.Discussingthepoliticsandvestedinterestsofvariouspartiesisbeyondthescopeofthispaper.Manyoftheseissuesarediscussedatlengthinthereferencedmaterials.Finally,therearethreeveryimportantpointsIwouldliketomakebeforeproceeding.First,iftheonlytoolyouhaveisahammer,allproblemsbecomenails.Thatis,ifyouhaveonesolution,youtendtoviewallproblemsintermsofthatsolution,evenwhenitiscompletelyinappropriatetodoso.Youmustremainopentothefactthatonesizeprobablydoesnotfitall.Thebiochemistryunderlyingmanycancers–andperhapsmostcancers–mayprovetobethesameandmaybeamenabletoacommonsolution.However,theremaybedifferentunderlyingbiochemicalmechanismsforsomecancersthatrequiredifferentsolutions.Thetrickisfiguringouthowtotellthedifference.Second,bythetimeyourcancerisdiscovered,atumormayhaveinvadedcriticaltissuescausingstructuraldamage.Itmaybethatthetumoritselfisnowholdingthingstogether.Thus,ifyoukillthetumoranditdecomposesrapidly,yourbodymaynotbeabletorepairthedamagedtissuebeforethereisatissuefailureorasecondarydiseaseprocesssetsin.Inotherwords,itmaynotbethecancerpersay

thatkillsyou–butyouarejustasdead.Thisscenarioismostlikelyinalaterstagediagnosis.Andfinally,thereareotherpotentialalternativeprotocolsoutthere.Someprotocolsmayhavealegitimatescientificbasiswhileothersmaynot.TestimonialsareNOTthesameasagoodmetastudy.Someoftheavailableprotocolsarequiteexpensiveandbeyondthemeansoftheaverageperson–sinceinsurancewillnotcovernon-conventionaltreatmentplans.Youarewelladvisedtocarefullyresearchtheliterature,payingcloseattentiontopublishedaccounts,studiesandtrials.JustrememberthatNET–asintheinternet–meansNotEntirelyTrue.Itisveryimportantyouseparatewishfulthinkingandhypefromvalidscienceandrealdata.AquickhistoryandoverviewDr.JohnBeardiscreditedwithfindingthelinkbetweentumors,trophoblastsandpancreaticenzymes.Thetrophoblastisthetissuethatgivesrisetotheplacentaandembryo.Ittookroughly20yearsofcarefulsciencetodiscoveranddocumentthesimilaritiesbetweentrophoblastsandtumors.Dr.Beardobservedthattrophoblastsandtumorsfunctionthesame–beforefinallydrawingtheconclusionthattheywerethesame–atumorbeinganinappropriatelylocatedtrophoblast.Dr.Beardalsonoticedthatthetrophoblasttransformationfrominvasivetumortomaturetissuetookplacewhenthepancreaswasdevelopedenoughtogenerateenzymes–aroundday56inhumanembryonicdevelopment.AfterDr.Beardfirstproposedusingsystemicpancreaticenzymestofightcancer(1902),doctorsbegantreatingpatientsandpublishingpapersdocumentingthattheprotocolworked.Dr.Beardpublishedhisbookonthesubjectin1911:TheEnzymeTreatmentofCancerandItsScientificBasis.Inscience,itisimportanttoseparatewhatyouknowfromwhatyoudon’tknow.Dr.Bearddiscoveredandcarefullydocumentedthatwhentheembryo’spancreasstartedtofunction,thetrophoblasttransformedfromactinglikeaninvasivetumortoactinglikeawell-behavedtissue–theplacenta.Dr.Beardassumedthatthethenknownpancreaticenzymeswerethecause.However,Dr.Beardneveractuallyisolatedoneormoresubstancesandshowedtheisolatedsubstance(s)tobethecauseoftheeffect.ThatwaswellbeyondthetechnologyavailablewhenDr.Beardwasalive.Dr.Beardusedfresh,grounduppancreatictissue(sometimesreferredtoaspancreatin)todemonstratetheeffect.Processedpancreatictissue(thepancreaticformulation)containsactiveenzymes.Butitalsocontainsenzymeprecursorsandother(potentiallyunknown)biochemicalsubstances.Dr.Beard’sobservedeffectisclearlytheresultofthepancreaticformulation.Wejustdon’tknowwhataspectoftheformulationisresponsiblefortheobservedeffects.

Forbrevity,clarityandconsistency,weusethephrase“pancreaticenzymes”toincludealloftheactivepancreaticenzymes,enzymeprecursorsandanyotherbiochemicalsubstancesthatmaybecontainedinapancreaticformulation.AlthoughtheactivepancreaticenzymeshadbeendiscoveredbythetimeDr.Beardwasdoinghiswork,itwasnotuntillongafterhisdeaththattheenzymeprecursorsandmostofthephysiologyofthepancreaswasunraveled.Forinstance,itwasonlyrecentlythatfattissue,asignificantcomponentofpancreatictissue,wasdiscoveredtogenerateawholearrayofsignalingfactors.Dr.Beardpointedoutinhisbookthatmanyfailuresattributedtohisprotocolwerecausedbydoctorsnotfollowinghisprotocoland/orbyusingpoorqualityformulations.Dr.Beardfounda400xrangeofstrengthinthecommonlyavailablepancreaticpreparationsavailableatthetime–clearlyaseriousqualitycontrolproblem.Butremember,inDr.Beard’stime,theyweretestingforaknownactiveenzyme.Theywerenottestingforenzymeprecursorsorotherfactors–whichwereunknowntothem.Dr.Beardgotaroundthisqualityissuebyinsistingonfreshpancreatictissuesforhisformulations.Itisinterestingtonotethatqualitycontrolissuescontinuedtoplaguetheenzymeproductionindustryuptomoderntimes.Dr.Beard’spancreaticformulationisbeingusedasasystemicdruginsteadofasadigestiveaid.Thismeansthatthepancreaticenzymesmustendupinthecirculatorysystemtohavethedesiredaffect.InDr.Beard’stime,itwasbelievedthatpancreaticenzymescouldnotsurviveoralconsumptionandwouldbedestroyedinthestomach.Further,itwasbelievedtheenzymemoleculesweretoolargetobeabsorbedthroughthesmallintestine.Asaresult,Dr.Beardprescribedthatpancreaticenzymesshouldbeadministeredviainjection.Onlymuchlaterwasitproventhatpancreaticenzymessurviveoralingestionandcanbeabsorbedthroughthesmallintestine.Recentresearchsuggestsbuthasnotproventhatpancreaticenzymeprecursorsareprobablytheaspectofthepancreaticformulationthatareactuallyprovidingtheanticanceraffect.TheseprecursorswouldhavebeenpartofDr.Beard’sformulationsgivenhisuseoffresh,grounduppancreatictissues.However,Dr.Beardwouldnothaveknownanythingaboutthem.MaxGersonwasadoctorwhodevelopedtheGersonprotocolandtreatedpatientsfor30years.Dr.Gersonpackagedpancreaticenzymes,anutrientdensemostlyvegetariandietwithlotsofrawjuice,supplementsanddetoxificationintoacomprehensivecancertreatmentprotocol.Dr.GersonknewaboutDr.Beard’sworkbutseemedtoplacemostofhisemphasisonthedigestivebenefitsofpancreaticformulationsratherthanonanydirectanticancerbenefit.Soitispossiblethat

Dr.Gersonbelievedthediet,ratherthantheenzymes,wasthecurativeagent.Followinghisdeath,hisdaughtercontinuedhisworkthroughtheGersonInstitute.WilliamKelleywasadentistwhodevelopedhisprotocolwhiletryingnottodieofpancreaticcancer.Extensiveexperimentationandhismother’sinfluenceresultedinaprotocolthatresembledtheGersonprotocol.Heapparentlydiscovered–independently–thatpancreaticenzymesworkoncancerwhiletakingmassiveoraldosesofpancreaticenzymestorelievehisseveregastrointestinaldistress–acommonsideaffectofpancreaticcancer.Whenthisalsoshrankhistumors,hebeganlookingforotherresearchandfoundDr.Beard’swork.Dr.Kelleywentintoremissionandwasabletolivealonghealthylife.Dr.Kelleycontinueddevelopinghisdietaryprotocol–hewasalsohelpingnon-cancerpatients.Dr.Kelleydiscoveredhisdietdidnotworkoncertainpatients.Hekeptexperimentinguntilhefoundsolutions.Thisledtothediscoveryofdifferentmetabolictypes–sympatheticsystemdominant,parasympatheticsystemdominantandbalancedmetabolizers.Thecurrentprotocolishighlytailoredtoeachmetabolictypeandrunstherangeofaredmeatdiettoanearlyvegetariandiet–withsignificantdifferencesinsupplementationtomatch.Dr.Kelleypublishedaself-testtoallowyoutodetermineyourmetabolictype.Dr.Kelleyobservedthatpeopleofthesympatheticsystemdominantmetabolictypewerepredisposedtosolidtumorcancerswhilepeopleoftheparasympatheticsystemdominantmetabolictypewerepredisposedtoimmunecellcancers.Peopleinthemiddledidnottendtogetcancerunlesstheyatealousydiet.Dr.Kelleybelievedthatfollowingahighqualitymetabolictype-appropriatedietwouldallowyoutoavoidcancer–andwasasignificantsteptowardcuringcancer.Dr.Kelleypublishedaprotocolfordetectingundetectedtumors.Theprotocolconsistsoftakingaregimentofpancreaticenzymesandwatchingforcertainsymptomstodevelop.Dr.Kelleyrecommendedapersondothisevery12to18monthsbecausecancerstendtobemanyyearsoldbeforetheycanbe(are)detected.Dr.Kelley’sestatehasupdatedandrepublishedhismostsignificantpublicationssotherearecurrentrevisionsavailable.NicholasGonzalezwasinmedicalschoolwhenhewasintroducedtotheworkofDr.KelleyandwasgivenfullaccesstoDr.Kelley’spatientrecords–some33,000ofthem.Afterextensiveanalysisshowedthattheprotocolproducedsignificantsuccesses,theresultswerewrittenupbutremainedunpublisheduntil2010becausenoonewaswillingtopublishthework.ThereisalinkbelowforaninterviewwithDr.Gonzalezthatcoversallofthisingreatdetail.Dr.GonzalezdiscoveredanissuewithDr.Kelley’sprotocolwhendoingtheextensivepatientfilereview.ThepatientrecordsshowedthatthesuccessratedroppedsignificantlywhenDr.Kelleychangedfromusinga4xpotencyformulation

tousinga10xpotencyformulation.Thereasonsbehindthisdropwasnotdiscovereduntilmuchlater–researchrevealedthathigherpotencyoftheactiveenzymesloweredthepotencyofthecorrespondingenzymeprecursorsandcontributestopotencyinstabilityduringnormalstorage.Dr.Gonzalez’sprotocolstartedwithDr.Kelley’sprotocolandaddedupdatesandfixesbasedoncurrentresearch.Dr.Gonzalezupdatedthepancreaticformulation,replacedthemetabolictypequestionnairewithahairtestandupdatedthesupplementslist.Dr.GonzalezdiedsuddenlyandunexpectedlyinJuly2015.Unfortunately,itappearsthatDr.Gonzalezneverpublishedadetailedprotocolspecification.Hiswifehasestablishedafoundationtocontinuehiswork.TheupdatedGonzalezpancreaticformulationmakesseveralimprovementstotheDr.KellyformulationandtheDr.Beardmethodology.AlthoughDr.Beard’sbasicconceptisbelievedtobecorrect,hedidnothavethetoolstounderstandwhyhisformulationsworkedandotherformulationsdidnot.NeitherdidDr.Kelley.Newresearchindicatesyouwantaformulationthathasbeenminimallyprocessedsoitishighinenzymeprecursors,lowinactiveenzymesandretainsthefatsoitwillremainpotencystableduringstorage.Dr.LindaIsaacsisafellowdoctorandresearcherwhoworkedwithDr.Gonzalez.Dr.Isaacsisthelastpracticingdoctorinthislineageandisthelastvesselofknowledgeforthemostup-to-dateversionofthisprotocol–everyoneelsehasdied.Dr.IsaacsisstillacceptingpatientsinherNewYorkCitypractice.Dr.JamesForsytheisadoctorpracticinginReno,Nevadawhohaspublishedstudiesofhistreatmentsystemandshownsignificantlybetterthanaveragetreatmentresults.AlthoughDr.ForsythedoesnotappeartobespecificallysubscribetotheBeardphilosophy,hedoessubscribetotestingforeffectivenesspriortoadministeringtreatmentsandthepublisheddatasuggestshismethodologydoesincreasethesurvivalrate.UnderstandingtheprotocolItishelpfultounderstandtheseparatepartsoftheprotocolsandwhateachpartaccomplishes.

• Pancreaticenzymesaretheanticanceragent.Theenzymesalsohelpwithwastingsyndrome(cachexia)–whichisdirectlyresponsiblefor1/3edofcancerdeaths.

• Anutrientdensedietwithlowcontaminantingredientsisusedtomaximizethehealthofthepatientandboosttheimmunesystem.Thesedietsaredesignedtorebuildthebodyandallowittofightoffanydiseaseprocessefficiently.Processedfoodsareshunned.Emphasisisonorganicallygrownformaximumnutrientvaluewithminimumchemicaltoxins.Similar

emphasisisplacedonmeat–forinstance,pasturedgrassfedbeefandlowmercurywild-caughtfish.Thevariousdietsincludesignificantrawcontentincludingtheuseofjuices.

• Supplementsareusedtoincreasethenutritionalvalueofthedietandmakeupforanyshortagesthatthedietmaynotbeabletoaddress.Thebody’shormoneproductiondecreaseswithageandcannotbereplacedbydietalone.

• Detoxification.Thisisdesignedtoincreasethebody’sabilitytogetridoftoxins.

Itisdangeroustokilltumorstoorapidlybecauserapidlydecomposingtumortissuecanpoisonandkillthepatient.Recentprotocolsarequitespecificinmakingsuretherateoftumordecompositioniscontrolled.Thisismostlyanissuewithalaterstagediagnosis.Theprotocoltypicallytakes6monthsto2years,dependingonthecircumstances.Tumorstendtostabilizequickly–overaperiodofafewmonths.Inotherwords,tumorstendtostopgrowingquicklyandthenbeginshrinking.However,itisnotunusualforasmallpercentageoftumorstopersistforseveralyearsbeforefinallydisappearing–eventhoughthepatientappearsingoodhealthandisasymptomatic.Onceyouhavebeendiagnosedwithcancer,youshouldconsiderpancreaticenzymesapermanentpartofyourlife.Althoughitmaybepossibletoreducethedosagebyhalf,thepancreaticenzymesshouldnotbediscontinued.Therearetworeasonsforthis.First,thereisnowaytoknowifyouhavebecomecancerfree–i.e.,ifyouarecured.Ifyouarenotcancerfreeandyoudiscontinuethepancreaticenzymes,thecancerislikelytocomeback.Second,youmaynothavechangedtheconditionsthatledtoyourfirstcancerdevelopingandthusyoumaydevelopanunrelatedsecondcancer.Itisknownthationizingradiation,chemicalsandvirusescanpredisposeyoutocancer.Butnobodyknowstheactualmechanismthatstartsthecancerprocessinmotion.Inbothcases,bythetimeyoudetectanewcancer,seriousdamagemayhavetakenplace.Attheveryleast,yourhealthandqualityoflifewillbesuffering.Itismuchsimplertocontinuethepancreaticenzymes,stayingoodhealth,enjoypeaceofmindandavoidthetraumaofanothercancerdiagnosis.Allhealthydietsystemstrytooptimizetheimmunesystem.Intheend,theimmunesystemiswhatwillkillandeliminatethecancercellsfromyourbody.Thesubjectofoptimumdietsiswellbeyondthescopeofthispaper.Sufficeittosay:The“diseasesofcivilization”aretheresultofthe“western”diet.

Thebiochemicalmechanismsthatallowthepancreaticenzymestoworkarenotfullyunderstood.Asaresult,theconditionsunderwhichthetherapymayfailtoworkarealsonotfullyunderstood.However,theliteratureindicatesthatthetherapyisquiteeffectivewithfew,ifany,negativesideaffects.Resources:linksThesearetoplevellinkstothemainwebsites:cancer.gov NationalCancerInstituteadjuvantonline.com Cancerprognosticsgerson.org GersonInstitutedrkelley.info Dr.WilliamDonaldKelleydr-gonzalez.com Dr.NicholasJ.Gonzalez,MDdrlindai.com Dr.LindaIsaacsThefollowinglinkistoapagecontainingalonginterviewwithDr.Gonzalezdiscussingthehistory,scienceandpoliticsofthetreatmentprotocol:http://www.drkelley.info/2015/11/10/dr-nicholas-gonzalez-interview-the-quest-for-the-cures/ThefollowingisadirectlinktotheYouTubevideooftheinterviewfromthepreviouslyreferencedlink:https://www.youtube.com/embed/zUQEpWSH9icThefollowingisalinktothearticleStatistics:WhyMeaningfulStatisticsCannotbeGeneratedFromaPrivatePractice:http://www.alternative-therapies.com/openaccess/ATHM_21_2_Gonzalez.pdfResources:booksThefollowingbooksarejustasmallsampleandrepresentagoodstartingpointforyourresearch.Rememberasyoureadthesebooksthatsciencehasnotstoodstillandyoushouldseekoutthemostreliableinformationavailable.Readingreferencedstudiesishardworkbutmaybeneededtoanswerquestions.Ifyouareonlygoingtoreadoneofthesebooks,readTheTrophoblastandtheOriginsofCancer:Onesolutiontothemedicalenigmaofourtimes.Itwillprovideyouwithagoodoverallunderstandingoftheconcepts,thescience,thehistory,thecurrentstateoftheartandsomepatientsummaries.

TheEnzymeTreatmentofCancerandItsScientificBasisJohnBeardD.Sc.ForewordbyNicholasJ.GonzalezMD2009(1911)ISBN:978-0-9821965-2-6

Dr.JohnBeard'sstudyofthemammalianplacentaledhimtotheconclusionthatinitsearlyincarnation,thistissuebehavesmuchasacanceroustumor.Hethenproposedthatpancreaticenzymesregulateplacentaldevelopment,andinturnrepresentthebody’smaindefenseagainstcancer.In1911,hepublishedthisbooktofavorablereviews.Thoughinhislifetimethescientificcommunityneverembracedhisideasaboutcancer–hediedinrelativeobscurityin1924–inrecentyears,evidencefrommolecularbiologyandstemcellresearchincreasinglyconfirmsmanyofDr.Beard’sfundamentalprecepts.Thishistoricworkisnowavailableagain,inacarefullyrecreatedreproductionwithaforewordbyDr.Gonzalez.TheTrophoblastandtheOriginsofCancer:OnesolutiontothemedicalenigmaofourtimesNicholasJ.Gonzalez,MDandLindaL.Isaacs,MD2009ISBN:978-0-9821965-0-2

Inthisbook,Dr.GonzalezandDr.IsaacsprovideacomprehensivereviewofDr.JohnBeard's100-year-oldtheoriesaboutcancer,fromtheperspectiveofcontemporarymolecularbiology.TheauthorsshowhowDr.Beardmostlikelydiscoveredstemcells,andverywellmayhaveuncoveredtherootoriginsofcancer-anditseffectivetreatmentwithproteolyticenzymes.ThebookincludesextensivecasehistoriesofcancerpatientssuccessfullytreatedwiththeGonzaleznutritional-enzymeregimen.

ConqueringCancer:VolumeOne-50PancreaticandBreastCancerPatientsonTheGonzalezNutritionalProtocolNicholasJ.Gonzalez,MD2015ISBN:978-09821965-5-7

ThiscancercasereportseriesdocumentstheeffectivenessofthenutritionalandenzymecancertreatmentdesignedbyNicholasJ.Gonzalez,MD.Thebookprovidesanin-depthanalysisoftheGonzalezProtocolinboththeoryandpractice,withfiftyrepresentativepatientswithbiopsy-provenpancreaticorbreastcancer.ThispioneeringbookincludespatientsdiagnosedwithapoorprognosisorterminalmalignancieswhodidwellunderDr.Gonzalez’scare.VolumeTwowillbeavailableinearly2017andwillcoverfifteenadditionaltypesofcancerandotherdegenerativediseases.ThesetwovolumesofConqueringCanceraretheculminationofDr.Gonzalez’stwenty-eight-yearmedicalcareer,ashediedsuddenlyandunexpectedlyinJuly2015.ACancerTherapy:Resultsof50casesMaxGerson2002(1958)ISBN-13:978-09611526-2-8

Dr.Gerson(1881-1959),whodevelopedtheGersonTherapy,explainshowthetreatmentreactivatesthebody'shealingmechanismsinchronicdegenerativediseases.ThisisthemostcompletebookontheGersonTherapy,originallypublishedin1958andbasedupon30yearsofclinicalexperimentation.

Thebookincorporatesextensiveexplanationofthetheorywithscientificresearchandtheexactpracticeofthetherapy,aswellasapresentationoffiftydocumentedcasehistories.AlsoincludedisamodifiedversionoftheGersonTherapyforusewithnonmalignantdiseasesorpreventativepurposes.TheGersonTherapy:TheProvenNutritionalProgramforCancerandOtherIllnessesCharlotteGerson,MortonWalker2001ISBN:978-15756662-8-0

Cancer.Hepatitis.Migraines.Arthritis.HeartDisease.Emphysema.Foryears,themedicalestablishmenthascalledthesechronicorlife-threateningdiseases"incurable."Butnow,TheGersonTherapyoffershopeforthoseseekingrelieffromhundredsofdifferentdiseases.Juiceyourwaytowellness.Oneofthefirstalternativecancertherapies,TheGersonTherapyhassuccessfullytreatedthousandsofpatientsforover60years.OneManAlone:AnInvestigationofNutrition,Cancer,andWilliamDonaldKelleyNicholasJ.Gonzalez,MD2010ISBN:978-0-9821965-1-9

Inthismonograph,Dr.Gonzalezdescribeshisinvestigationofthenutritional/enzymecancertreatmentdevelopedbythealternativepractitionerDr.WilliamDonaldKelley.InadditiontoadiscussionofKelley'streatmentapproach,thebookincludes50casehistoriesofsuccessfullytreatedcancerpatients.Although

firstcompletedin1986,thismonographwasnotpublisheduntil2010,rewrittenandwithanupdatedintroductionbyDr.Gonzalez.Thebookisnowavailabletoallthosewithaninterestincanceringeneral,theenzymetreatmentofcancerinparticular,alternativemedicine,andDr.Kelley.VICTORYOverCancer:withoutSurgery,Chemotherapy,orRadiationDr.WilliamD.Kelley2015(KettleMoraine,thebookshelf.us)ISBN:978-0-578-16518-9

Inthisupdatedandgreatlyexpandedbook,Dr.WilliamD.Kelleyteachesthat,notonlyistherearecognizedcureforcancer–butthatcancerispreventable!ThisisareconsiderationofDr.Kelley’soriginalbook,OneAnswertoCancerpublishednearlyfive-decadesago–andnowgreatlyexpanded.(Alsoreplacing,CANCER:CuringtheIncurablewithoutSurgery,ChemotherapyorRadiation).CancerispreventableANDcurableandthis200+pagebookwillshowyouhowtoinsurethatyou’lllivealong,healthy,cancerfreelife.Dr.Kelley’sSelfTestfortheDifferentMetabolicTypesDr.WilliamD.Kelley2014(KettleMoraine,thebookshelf.us)ISBN:978-1-620-30413-6

Dr.KelleydevelopedhisSelf-TestfortheDifferentMetabolicTypesinthe1960′stohelpbridgethegapofresearchtopracticalapplication.Herealizedthattheoverallstateofhealthofthisnationcouldnolongerbemaintainedacceptableunlessthenutritionalneedsofthepeoplewerebroughtintoimmediateandsharpfocus.Noone(doctororpatient)knowswhatawell-balancedmealis.Doctorshavenotbeen

trainedalongthesedisciplines,nordotheyhavethetimeorinclinationtoeducatethemselvesintheseareas.WhatWentWrong:TheTruthBehindtheClinicalTrialoftheEnzymeTreatmentofCancerNicholasJ.Gonzalez,MD2012ISBN:978-0-9821965-3-3

Dr.GonzalezchroniclesthefailureoftheNationalCancerInstitute(NIH)fundedclinicaltrialconductedundertheauspicesofColumbiaUniversity,setuptotesthisnutritionaltreatmentinpatientsdiagnosedwithpancreaticcancer.Inthisfirst-handaccount,Dr.Gonzalezrevealshowpoortrialdesignandpoorimplementationatthehighestlevelsoftheacademicresearchworldhelpedunderminethispromisingproject.ThebookdiscussesindetailtwoofficialgovernmentinvestigationsthathaveconfirmedDr.Gonzalez’sallegationsthatthestudywasnotproperlysupervised.Dr.Gonzalezalsoillustratesthebiaseswithinthescientificcommunitythatmakefairtestingofunconventionaltreatmentssodifficult.EnzymesandCancer(DVD)NicholasJ.Gonzalez,MD2008

Dr.NicholasGonzalezdiscussesthescientificsupportforhisnutritionalapproachtocancerandotherdegenerativediseasesinaspeechtitled“EnzymesandCancer.”PresentedattheWiseTraditionsconferencesponsoredbytheWestonA.PriceFoundation.

DifferentDietsforDifferentTypes(DVD)NicholasJ.Gonzalez,MD2014

Dr.Gonzalezdiscussesthephysiologyandbiochemistryofdietandnutritionandtheuseofdietandnutrientstotreatdisease,againwithemphasisonthepioneeringworkofWestonPrice,DDS,FrancisPottenger,MD,andWilliamKelley,DDS.PresentedattheALLDOCSAnnualConferenceinSanMarco,Florida.Resources:pancreaticenzymesThisisthesystemicpancreaticformulationdevelopedbyDr.Gonzalez.Theformulationischaracterizedasminimallyprocessedforhighprecursorenzymecontent,lowactiveenzymecontentwithfatretainedforshelfstablepotency.Thelabelliststhedosageas3perday.However,thepublishedliteratureindicatesthedosedependsonyourcancerstage.Stage3andstage4cancersrequire35g/day(81capsulesperday).State2andstage1cancersrequire25g/day(61capsulesperday).Onceyouareinremission,take11g/day(25capsulesperday)topreventreoccurrencesornewcancers.Thepublishedliteratureindicatespancreaticenzymesaretakenforatleast3buttypicallynomorethan16consecutivedays.Thisisfollowedbya5dayrestperiodduringwhichnopancreaticenzymesaretaken-allowingthebodytorepairanddetoxify.Thecycleisthenrepeated.NutriCologyisamarketingnameforAllergyResearchGroup.NutriCologyPancreas,NaturalGlandular(Pork),425mgcapsules,720countUPC:713947516502